Life Science News

Company News

M Pharmaceutical Inc. (CSE:MQ) announced that Dr. Martin Mintchev, PhD, has resigned from the board of directors of M Pharmaceutical Inc. and from his position as chief scientific officer with immediate effect.

M Pharmaceutical Inc. (CSE:MQ) announced that Dr. Martin Mintchev, PhD, has resigned from the board of directors of M Pharmaceutical Inc. and from his position as chief scientific officer with immediate effect.
M Pharma recently announced it had entered into a letter of intent to acquire reformulated orlistat from Chelatexx LLC (C-103) and a significant reorganization of its priorities to concentrate on the development of oral products for obesity treatment and weight loss. The management of M Pharma and Chelatexx LLC are currently reviewing the proposed acquisition structure for tax efficiency.
M Pharmaceutical CEO, Matthew Lehman, stated:

On behalf of the M Pharma board of directors, we thank Dr. Mintchev for his service to help start the company. His creative insights are the driving factor behind much of M Pharma’s innovative technology. We wish him well with his teaching and research endeavours.

Connect with M Pharmaceutical Inc. (CSE:MQ) to receive an Investor Kit

MARKETS

Markets
TSX19222.74-35.58
TSXV644.91-7.45
DOW30946.99-491.27
S&P 5003821.55-78.56
NASD11181.54-343.01
ASX6763.60+57.60

COMMODITIES

Commodities
Gold1816.18-2.38
Silver20.81-0.01
Copper3.77-0.01
Palladium1912.50+43.50
Platinum927.50+17.50
Oil112.23+0.47
Heating Oil4.03-0.09
Natural Gas6.77+0.20

DOWNLOAD FREE REPORTS

×